- Home
- FBYD vs VIGL Comparison
FBYD vs VIGL Comparison
Compare FBYD & VIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBYD
- VIGL
- Stock Information
- Founded
- FBYD 2021
- VIGL 2020
- Country
- FBYD United States
- VIGL United States
- Employees
- FBYD N/A
- VIGL N/A
- Industry
- FBYD
- VIGL Biotechnology: Pharmaceutical Preparations
- Sector
- FBYD
- VIGL Health Care
- Exchange
- FBYD Nasdaq
- VIGL Nasdaq
- Market Cap
- FBYD 255.4M
- VIGL 134.9M
- IPO Year
- FBYD N/A
- VIGL 2022
- Fundamental
- Price
- FBYD $5.75
- VIGL $7.99
- Analyst Decision
- FBYD
- VIGL Buy
- Analyst Count
- FBYD 0
- VIGL 7
- Target Price
- FBYD N/A
- VIGL $8.00
- AVG Volume (30 Days)
- FBYD 26.5K
- VIGL 1.6M
- Earning Date
- FBYD 08-12-2025
- VIGL 08-12-2025
- Dividend Yield
- FBYD N/A
- VIGL N/A
- EPS Growth
- FBYD N/A
- VIGL N/A
- EPS
- FBYD N/A
- VIGL N/A
- Revenue
- FBYD $6,937,000.00
- VIGL N/A
- Revenue This Year
- FBYD N/A
- VIGL N/A
- Revenue Next Year
- FBYD N/A
- VIGL N/A
- P/E Ratio
- FBYD $370.59
- VIGL N/A
- Revenue Growth
- FBYD N/A
- VIGL N/A
- 52 Week Low
- FBYD $3.62
- VIGL $1.31
- 52 Week High
- FBYD $13.25
- VIGL $8.00
- Technical
- Relative Strength Index (RSI)
- FBYD 44.65
- VIGL 88.87
- Support Level
- FBYD $5.63
- VIGL $7.86
- Resistance Level
- FBYD $6.46
- VIGL $7.96
- Average True Range (ATR)
- FBYD 0.83
- VIGL 0.02
- MACD
- FBYD 0.06
- VIGL -0.18
- Stochastic Oscillator
- FBYD 39.00
- VIGL 93.33
About FBYD Falcon's Beyond Global Inc.
Falcons Beyond Global Inc. is a Company that provides a full range of theme park design, master planning, and experiential technologies for customers in the entertainment and attraction industry through its Falcon's Creative Group reportable segment and develops and co-owns resort and theme park attractions through its Destinations Operations. The Company has four operating segments, Falcon's Creative Group, PDP, Falcon's Beyond Brands, and Destinations Operations, all of which are reportable segments. It earns the majority of the revenue from Falcon's Creative Group segment.
About VIGL Vigil Neuroscience Inc.
Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.